GI CANCERS

Latest News

Adding Bevacizumab Improves PFS, But Not OS, in Advanced Biliary Tract Cancer
Adding Bevacizumab Improves PFS, But Not OS, in Advanced Biliary Tract Cancer

November 6th 2024

Bevacizumab in combination with atezolizumab and chemotherapy led to improvements in progression-free survival and duration of response in patients with advanced biliary tract cancer.

FDA Clears Phase 2 Trial of Leronlimab for Microsatellite-Stable CRC
FDA Clears Phase 2 Trial of Leronlimab for Microsatellite-Stable CRC

November 6th 2024

Lenvatinib/Pembrolizumab/TACE Regimen Improves PFS in Intermediate-Stage HCC
Lenvatinib/Pembrolizumab/TACE Regimen Improves PFS in Intermediate-Stage HCC

October 28th 2024

Zolbetuximab Scores FDA Approval in CLDN 18.2+ Gastric/GEJ Cancer
Zolbetuximab Scores FDA Approval in CLDN 18.2+ Gastric/GEJ Cancer

October 18th 2024

FDA Pushes Back Decision on Sotorasib/Panitumumab in Colorectal Cancer
FDA Pushes Back Decision on Sotorasib/Panitumumab in Colorectal Cancer

October 18th 2024

More News